| Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype V Bazan, M Migliavacca, I Zanna, C Tubiolo, N Grassi, MA Latteri, ... Annals of Oncology 13 (9), 1438-1446, 2002 | 310 | 2002 |
| Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores J Lecarpentier, V Silvestri, KB Kuchenbaecker, D Barrowdale, J Dennis, ... Journal of Clinical Oncology 35 (20), 2240-2250, 2017 | 198 | 2017 |
| Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival M Falchetti, C Saieva, R Lupi, G Masala, P Rizzolo, I Zanna, K Ceccarelli, ... Human pathology 39 (6), 925-932, 2008 | 175 | 2008 |
| Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 V Silvestri, D Barrowdale, AM Mulligan, SL Neuhausen, S Fox, BY Karlan, ... Breast Cancer Research 18, 1-13, 2016 | 150 | 2016 |
| Clinical characteristics and overall survival in genitourinary sarcomas treated with curative intent: a multicenter study N Mondaini, D Palli, C Saieva, G Nesi, A Franchi, R Ponchietti, S Tripodi, ... European urology 47 (4), 468-473, 2005 | 135 | 2005 |
| Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer D Palli, S Polidoro, M D'Errico, C Saieva, S Guarrera, AS Calcagnile, ... Mutagenesis 25 (6), 569-575, 2010 | 130 | 2010 |
| Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk N Orr, A Lemnrau, R Cooke, O Fletcher, K Tomczyk, M Jones, N Johnson, ... Nature genetics 44 (11), 1182-1184, 2012 | 124 | 2012 |
| Clinical and pathologic characteristics of BRCA-positive and BRCA-negative male breast cancer patients: results from a collaborative multicenter study in Italy L Ottini, V Silvestri, P Rizzolo, M Falchetti, I Zanna, C Saieva, G Masala, ... Breast cancer research and treatment 134, 411-418, 2012 | 113 | 2012 |
| Interleukin-1 gene polymorphisms and gastric cancer risk in a high-risk Italian population D Palli, C Saieva, I Luzzi, G Masala, S Topa, F Sera, S Gemma, I Zanna, ... Official journal of the American College of Gastroenterology| ACG 100 (9 …, 2005 | 107 | 2005 |
| Twenty-four-hour urinary excretion of ten pesticide metabolites in healthy adults in two different areas of Italy (Florence and Ragusa) C Saieva, C Aprea, R Tumino, G Masala, S Salvini, G Frasca, ... Science of the total environment 332 (1-3), 71-80, 2004 | 100 | 2004 |
| Divergent patterns of total and cancer mortality in ulcerative colitis and Crohn’s disease patients: the Florence IBD study 1978–2001 G Masala, S Bagnoli, M Ceroti, C Saieva, G Trallori, I Zanna, G d’Albasio, ... Gut 53 (9), 1309-1313, 2004 | 87 | 2004 |
| BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy L Ottini, P Rizzolo, I Zanna, M Falchetti, G Masala, K Ceccarelli, V Vezzosi, ... Breast cancer research and treatment 116, 577-586, 2009 | 83 | 2009 |
| GSTT1 and GSTM1 gene polymorphisms and gastric cancer in a high‐risk italian population D Palli, C Saieva, S Gemma, G Masala, MJ Gomez‐Miguel, I Luzzi, ... International journal of cancer 115 (2), 284-289, 2005 | 81 | 2005 |
| MRE11 expression is impaired in gastric cancer with microsatellite instability L Ottini, M Falchetti, C Saieva, M De Marco, G Masala, I Zanna, ... Carcinogenesis 25 (12), 2337-2343, 2004 | 72 | 2004 |
| DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study V Bazan, M Migliavacca, I Zanna, C Tubiolo, S Corsale, V Calo, A Amato, ... Journal of cancer research and clinical oncology 128, 650-658, 2002 | 64 | 2002 |
| BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases M Falchetti, R Lupi, P Rizzolo, K Ceccarelli, I Zanna, V Calo, S Tommasi, ... Breast cancer research and treatment 110, 161-167, 2008 | 61 | 2008 |
| PALB2 mutations in male breast cancer: a population-based study in Central Italy V Silvestri, P Rizzolo, I Zanna, M Falchetti, G Masala, S Bianchi, L Papi, ... Breast cancer research and treatment 122, 299-301, 2010 | 60 | 2010 |
| Prognostic significance of p16INK4a alterations and 9p21 loss of heterozigosity in locally advanced laryngeal squamous cell carcinoma V Bazan, I Zanna, M Migliavacca, MT Sanz‐Casla, ML Maestro, S Corsale, ... Journal of cellular physiology 192 (3), 286-293, 2002 | 59 | 2002 |
| Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma A Russo, V Bazan, M Migliavacca, I Zanna, C Tubiolo, FM Tumminello, ... Clinical cancer research 6 (1), 178-184, 2000 | 57 | 2000 |
| A PALB2 germline mutation associated with hereditary breast cancer in Italy L Papi, AL Putignano, C Congregati, I Piaceri, I Zanna, F Sera, D Morrone, ... Familial cancer 9, 181-185, 2010 | 56 | 2010 |
domenico palliISPRO-EpidemiologiaEmail verificata su ispro.toscana.it
